Compare ARES & VEEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARES | VEEV |
|---|---|---|
| Founded | 1997 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Computer Software: Prepackaged Software |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.1B | 39.5B |
| IPO Year | 2014 | 2013 |
| Metric | ARES | VEEV |
|---|---|---|
| Price | $173.92 | $223.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 27 |
| Target Price | $190.33 | ★ $299.92 |
| AVG Volume (30 Days) | ★ 4.8M | 1.9M |
| Earning Date | 11-03-2025 | 11-20-2025 |
| Dividend Yield | ★ 2.58% | N/A |
| EPS Growth | 9.11 | ★ 26.69 |
| EPS | 2.38 | ★ 5.13 |
| Revenue | ★ $5,355,558,000.00 | $3,080,246,000.00 |
| Revenue This Year | $16.40 | $17.74 |
| Revenue Next Year | $23.00 | $12.24 |
| P/E Ratio | $72.90 | ★ $43.52 |
| Revenue Growth | ★ 45.54 | 15.96 |
| 52 Week Low | $110.63 | $201.54 |
| 52 Week High | $200.49 | $310.50 |
| Indicator | ARES | VEEV |
|---|---|---|
| Relative Strength Index (RSI) | 71.87 | 18.87 |
| Support Level | $160.00 | $236.95 |
| Resistance Level | $181.19 | $246.57 |
| Average True Range (ATR) | 4.80 | 6.67 |
| MACD | 2.41 | -1.06 |
| Stochastic Oscillator | 80.53 | 22.23 |
Ares Management is one of the world's largest alternative-asset managers, with $595.7 billion in total assets under management, or AUM, including $367.6 billion in fee-earning AUM, at the end of September 2025. The company has four main business segments: private credit ($391.5 billion in total AUM and $240.2 billion in fee-earning AUM), private equity, ($25.1 billion/$11.8 billion), real estate/real assets ($132.4 billion/$80.5 billion), and other alternatives ($46.7 billion/$35.1 billion). The firm primarily serves institutional investors (80% of AUM) and high-net-worth individuals (20%). Ares operates through more than 35 offices in over 15 countries around the globe.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.